Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Marsh McLennan (MRSH)

NYSE: MRSH · Insurance Brokers · New York, NY

Our rating: Positive

Positive reaffirmed at $188.35, moderate conviction, October 16, 2026.

Breaks if: The Positive call depends on top-line momentum and capital returns holding near current levels. It is invalidated if revenue growth reported in the next two consecutive 10-Q filings falls below 6% — roughly half the current 10.3% pace — because at 5.87× book there is no valuation cushion to absorb a deceleration of that size without a meaningful re-rating. Separately, if ROE slips below 22% in the next annual filing, the premium over book becomes structurally harder to defend and the case moves to Neutral.

Key figures

Market value$98.1B
Revenue, last 12 months$28.5B
Net income, last 12 months$4.0B
Free cash flow, last 12 months$4.2B
Price to earnings24.3×
Free cash flow yield4.2%
Dividend yield1.8%
Operating margin21.4%
Return on equity26.7%
Beta to the S&P 5000.15
Volatility, annualized21.9%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$6.9B8.1%$1.69$1.4B
June 30, 2026$7.4B6.2%$2.63$1.5B
March 31, 2026$7.6B7.6%$2.36−$750M
December 31, 2025$6.6B8.7%$1.68$2.1B
September 30, 2025$6.4B11.5%$1.51$2.0B
June 30, 2025$7.0B12.1%$2.45$1.6B
March 31, 2025$7.1B9.1%$2.79−$677M
December 31, 2024$6.1B9.2%$1.59$1.9B

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

14 ledger entries and 41 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.